Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[ION582]1件: ION582---1件: 201 💬
2[RO7248824/F02-01]----1件: 201 💬
3Acylated and unacylated ghrelin dosages----3件: 193, 201, 202 💬
4Aknemin 50----1件: 201 💬
5Alogabat1件: Alogabat1件: Alogabat 💬 1件: GABRA5 💬 8件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬1件: 201 💬
6Betaine1件: Betaine3件: Betaine hydrochloride ,
Betaine ,
Betaine citrate 💬 		--4件: 117, 201, 234, 337 💬
7Blood Collection----5件: 21, 65, 201, 229, 271 💬
8CARBIDOPA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 6, 13, 17, 90, 140, 164, 201 💬
9Creatine1件: Creatine---18件: 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
10ELLIOTTS B® SOLUTION----1件: 201 💬
11ELLIOTTS B® SOLUTION (buffered intrathecal electrolyte/dextrose injection)----1件: 201 💬
12ELLIOTTS B® SOLUTION (buffered intrathecal electrolyte/dextrose injection)Product Name: ELLIOTTS B® SOLUTIONProduct Code: ELLIOTTS B® SOLUTIONPharmaceutical Form: Solution for injection----1件: 201 💬
13Gaboxadol1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 201, 206 💬
14GABOXADOL MONOHYDRATE1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
15Gaboxadol monohydrate 0.5 mg1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
16Gaboxadol monohydrate 0.5 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
17Gaboxadol monohydrate 0.5 mg capsule1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
18Gaboxadol monohydrate 2 mg1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
19Gaboxadol monohydrate 2 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
20Gaboxadol monohydrate 2 mg capsule1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
21Gaboxadol monohydrate 5 mg1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
22Gaboxadol monohydrate 5 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
23Genetic: MVX-220----1件: 201 💬
24GTX-102----1件: 201 💬
25GTX-102Product Code: GTX-102Pharmaceutical Form: Solution for injectionINN or Proposed INN: Not availableCurrent Sponsor code: GTX-102Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 11-----1件: 201 💬
26ION5821件: ION582---1件: 201 💬
27Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬8件: 5, 6, 17, 90, 120, 140, 164, 201 💬
28Levodopa/Carbidopa (4:1)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 201 💬
29Lumbar puncture----9件: 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
30Metafolin----1件: 201 💬
31Minocycline1件: Minocycline2件: Minocycline hydrochloride ,
Minocycline 💬 		--14件: 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
32Minocycline Hydrochloride1件: Minocycline2件: Minocycline hydrochloride ,
Minocycline 💬 		--4件: 13, 201, 206, 299 💬
33NNZ-25911件: NNZ-2591---2件: 193, 201 💬
34Non disponibile----2件: 13, 201 💬
35Nutritional Formulation Containing Exogenous Ketones----1件: 201 💬
36Other: No intervention----5件: 6, 70, 96, 97, 201 💬
37OV101----2件: 201, 206 💬
38OV101 Regimen 1----1件: 201 💬
39OV101 regimen 2----1件: 201 💬
40RO7248824----1件: 201 💬
41RO7248824/F02-01----1件: 201 💬
42RO7248824/F03-01 (Diluent for RO7248824/F02-01----1件: 201 💬
43Rugonersen1件: Rugonersen---1件: 201 💬
44Sham Procedure----3件: 3, 201, 339 💬
45Sham-LP----1件: 201 💬
46Taurine1件: Taurine1件: Taurine 💬 --4件: 13, 21, 201, 337 💬
47Vitamin B12----2件: 6, 201 💬